Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Acute Myeloid Leukemia Market In The Coming Years?
The market size for acute myeloid leukemia has seen significant growth in recent years. The market size is projected to climb from $3.5 billion in 2024 to $3.73 billion in the following year, with a compound annual growth rate (CAGR) of 6.7%. The expansion during the historical period can be credited to factors such as an increase in the aging population, environmental influences, genetic factors, a lack of treatment alternatives, and advancements in medical sciences.
The market size for acute myeloid leukemia is predicted to experience robust expansion in the upcoming years. By 2029, it will amplify to $4.9 billion with a 7.0% compound annual growth rate (CAGR). This growth in the forecast period is linked to advancements in targeted therapies, the progression of immunotherapies, approaches in precision medicine, rise in awareness and early detection, joint research initiatives. Key trends within the forecast period cover minimal residual disease monitoring, application of artificial intelligence (AI) in treatment decisions, emphasis on supportive care and interventions to improve the quality of life, combined research initiatives and clinical tests, programs for patient advocacy and empowerment.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6100&type=smp
What Drivers Are Accelerating Expansion Of The Acute Myeloid Leukemia Market?
The surge in the elderly demographic and increasing unmet healthcare demands are predicted to stimulate the expansion of the acute myeloid leukemia market in the ensuing years. The terms geriatric population and rising unmet healthcare denote the population aged 65 years and above, who are battling health complications such as acute myeloid leukemia. For example, as stated by the American Cancer Society USA (ACS), a nationwide health organization operating on a voluntary basis, AML was predominantly identified in older individuals in 2022, with the average age of diagnosis being 68. The survival rate amongst these elderly patients suffering from AML was alarmingly low. Approximately 60,650 individuals were affected by it in 2022, leading to 24000 fatalities. Consequently, the aging population and escalating unmet healthcare demands spearhead the growth in the gelatin market.
How Is The Global Acute Myeloid Leukemia Market Broken Down By Segment?
The acute myeloid leukemiamarket covered in this report is segmented –
1) By Treatment Type: Chemotherapy; Radiation therapy; Stem Cell Transplant; Targeted Therapy
2) By Chemotherapy: Cytarabine; Anthracycline Drugs; Alkylating Agents; Anti-metabolites; Tyrosine Kinase Inhibitors; Hormonal Therapy
3) By Regimen: DC Regimen; AVD Regimen; VCD Regimen
4) By End-User: Hospital; Retails Drug Stores; Ambulatory Care Centers; Clinics
Subsegments:
1) By Chemotherapy: Induction Chemotherapy; Consolidation Chemotherapy
2) By Radiation Therapy: Total Body Irradiation; Localized Radiation Therapy
3) By Stem Cell Transplant: Autologous Stem Cell Transplant; Allogeneic Stem Cell Transplant
4) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs); Monoclonal Antibodies; Other Targeted Agents
Which Market Trends Are Expected To Define The Future Of The Acute Myeloid Leukemia Market?
The acute myeloid leukemia market is seeing a trend of increased investment in research and development by pharmaceutical entities. The purpose of such R&D is to create new and innovative products and services to meet drug development requirements. For example, as reported by the National Library of Medicine, a national medical library based in the US, a study called ‘Daunorubicin or Idarubicin with Cytarabine Plus Quizartinib vs. Physician’s Choice in Newly Diagnosed FLT3-ITD+ AML (Q-SOC)’ entered Phase III of clinical trials in May 2022. This trial, which began in November 2021, is expected to come to completion by March 2025.
Which Firms Are Making The Biggest Impact In The Acute Myeloid Leukemia Market?
Major companies operating in the acute myeloid leukemia market include Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Sanofi-Aventis (Genzyme Corporation), Bristol Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceuticals, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical, Celgene Corporation, Astellas Pharma, Servier Pharmaceuticals, CSPC Pharmaceutical Group, Genmab AS, Zhejiang Medicine Co. Ltd., Syndax Pharmaceuticals Inc., Astex Pharmaceuticals Inc., MEI Pharma Inc., SELLAS Life Sciences Group, Ambit Biosciences Corporation, Agios Pharmaceuticals Inc., Neomed Management AS, Oncolyze Inc., TC BioPharm, VERASTEM INC., Mirati Therapeutics Inc., Sunshine Lake Pharma, Sunesis Pharmaceuticals Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/acute-myeloid-leukemia-global-market-report
Which Geographic Regions Are Creating Strong Demand In The Acute Myeloid Leukemia Market?
North America was the largest region in the acute myeloid leukemia market in 2024. The regions covered in the acute myeloid leukemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=6100&type=smp
Browse Through More Reports Similar to the Global Acute Myeloid Leukemia Market 2025, By The Business Research Company
Pain Management Devices And Therapies Global Market Report 2025
Metabolomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report
Isothermal Nucleic Acid Amplification Technology Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model